Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series C
Biotech
Soley secures $200M series C to take cell stress drug to clinic
Soley has secured $200 million in series C funds, which the AI-enabled biotech plans to use to take its lead leukemia asset into the clinic.
James Waldron
Jan 7, 2026 8:55am
Fierce Biotech Fundraising Tracker: Syneron, Atavistik & more
Dec 19, 2025 2:00pm
Aspen adds $115M series C to grow cell therapy ambitions
Nov 20, 2025 7:02am
Hemab raises $157M series C for rare bleeding disorder goals
Oct 27, 2025 6:00am
Fierce Pharma
Veradermics grows hair loss med hopes on $150M funding wave
Oct 16, 2025 7:30am
Tubulis touts $361M series C as next-gen ADC data drop nears
Oct 15, 2025 5:01am
